About
James Peyer, PhD, is the founder and CEO of Cambrian Bio, a clinical-stage biotech focused on medicines targeting age-related disease and healthspan. Before Cambrian, he founded and served as Managing Partner of Apollo Ventures/Apollo Health Ventures, an early longevity-focused venture firm, and helped launch companies including Cleara and Samsara. His background spans stem cell biology at UT Southwestern, biotech strategy at McKinsey, venture creation, and biotech board service.
Areas of interest
longevitybiotechgeroscienceage-related diseasespreventive medicinedrug developmentventure creationcell therapywomen's healthcardiometabolic diseaseoncologyautophagy